Sedative, hypnotic or anxiolytic use disorder, moderate, in early remission
Sedative, hypnotic or anxiolytic use disorder, moderate, in sustained remission
Sedative, hypnotic or anxiolytic use disorder, severe, in early remission
Sedative, hypnotic or anxiolytic use disorder, severe, in sustained remission
Barbiturate dependence in remission
Hypnotic or anxiolytic dependence in remission
Sedative, hypnotic and/or anxiolytic dependence, moderate use, in early remission
Sedative, hypnotic and/or anxiolytic dependence, moderate use, in sustained remission
Sedative, hypnotic and/or anxiolytic dependence, severe use, in early remission
Sedative, hypnotic and/or anxiolytic dependence, severe use, in sustained remission
Sedative, hypnotic or anxiolytic dependence moderate use disorder), in early remission
Sedative, hypnotic or anxiolytic dependence moderate use disorder), in sustained remission
Sedative, hypnotic or anxiolytic dependence severe use disorder), in early remission
Sedative, hypnotic or anxiolytic dependence severe use disorder), in sustained remission
F13.21 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
The 2023 edition of ICD-10-CM F13.21 became effective on October 1, 2022.
This is the American ICD-10-CM version of F13.21 – other international versions of ICD-10 F13.21 may differ.